Live Breaking News & Updates on Investment in biotechnology companies

Stay updated with breaking news from Investment in biotechnology companies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer

Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , California , United-states , Melbourne , Victoria , Sam-martin , Timothye-morris , Rudi-michelson , Megan-baldwin , Iovance-biotherapeutics , Questcor-pharmaceuticals-inc , Acelrx-pharmaceuticals

Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer

Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , California , United-states , Melbourne , Victoria , Rudi-michelsonmonsoon-communicationstel , Timothye-morris , Megan-baldwin , Iovance-biotherapeutics , Questcor-pharmaceuticals-inc , Acelrx-pharmaceuticals , Humanetics-corporation

Opthea Announces Presentation at H.C. Wainwright 2nd Annual

MELBOURNE, Australia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel...

Australia , Melbourne , Victoria , Sam-martin , Rudi-michelson , Megan-baldwin , Silvana-guerci-lena , Investment-in-biotechnology-companies , Company-media-enquiries , Monsoon-communications , Opthea-limited , Nasdaq

Opthea Presentation at The Ret - GuruFocus.com

GuruFocus Article or News written by GuruFocusNews and the topic is about:

University-of-southern-california , California , United-states , Florida , Fort-lauderdale , Australia , Melbourne , Victoria , Sam-martin , David-boyer , Rudi-michelson , Silvana-guerci-lena

Opthea Presentation at The Retina World Congress 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

University-of-southern-california , California , United-states , Florida , Fort-lauderdale , Australia , Melbourne , Victoria , Sam-martin , David-boyer , Rudi-michelson , Silvana-guerci-lena

Opthea strengthens its Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

South-africa , Australia , Melbourne , Victoria , United-states , American , Sam-martin , Claris-biotherapeutics , Jeremy-levin , Quinton-oswald , Rudi-michelson , Megan-baldwin

Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief ...

Key appointment as Opthea progresses the Phase 3 clinical development of OPT-302 in wet AMD

Australia , United-states , Melbourne , Victoria , Toronto , Ontario , Canada , Israel , Vancouver , British-columbia , Joel-naor , Megan-baldwin

Opthea Data for OPT-302 in Patients with Polypoidal Choroidal Vasculopathy (PCV) Presented at Angiogenesis 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Australia , United-states , Melbourne , Victoria , Singapore , Sam-martin , Bascom-palmer , Rudi-michelson , Polypoidal-choroidal-vasculopathy , Megan-baldwin , Retina-department , Nasdaq

Opthea To Present at H.C. Wainwright BIOCONNECT Virtual Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Australia , Melbourne , Victoria , Sam-martin , Rudi-michelson , Megan-baldwin , Investment-in-biotechnology-companies , Company-media-enquiries , Monsoon-communications , Opthea-limited , Nasdaq , Chief-executive-officer

Opthea Opens Patient Enrollment in the Asia-Pacific Region for the OPT-302 ShORe and COAST ...

MELBOURNE, Australia, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced

Australia , Philippines , United-states , Melbourne , Victoria , Canada , South-korea , Megan-baldwin , Investment-in-biotechnology-companies , European-medicines-agency , Facebook , Drug-administration